Clinical trials
Phase 2 Heart Defects, Congenital trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 2 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardurion Pharmaceuticals, Inc. | 1 |
| IRCCS Policlinico S. Donato | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Defects, Congenital | 3 |
| Afibrinogenemia | 1 |
| Blood Platelet Disorders | 1 |
| Heart Diseases | 1 |
| Hemophilia B | 1 |
| Hemorrhage | 1 |
| Tachycardia, Ventricular | 1 |
| Thrombosis | 1 |
| Transfusion Reaction | 1 |
| Transfusion-Related Acute Lung Injury | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.